MacDonald Mines Announces Further Increase of Flow-Through Private Placement to $4,000,000
TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — MacDonald Mines Exploration Ltd. (TSX-V: BMK) (“MacDonald Mines”, “MacDonald” or the “Company”) announces […]
REPEAT – African Gold Group Files NI 43-101 Technical Report for Kobada Gold Project
TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — African Gold Group, Inc. (TSX-V: AGG) (“AGG” or the “Company”) is pleased to […]
Yamana Gold Announces Preliminary Second Quarter 2020 Results; Further Balance Sheet Improvements; Ramp-Up at Canadian Malartic Completed Faster Than Anticipated With Record Tonnes Milled in May
TORONTO, July 13, 2020 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX: YRI; NYSE: AUY) (“Yamana” or “the Company”) announces preliminary second quarter 2020 results, […]
Major Precious Plans Site Visit to Skaergaard
VANCOUVER, British Columbia, July 13, 2020 (GLOBE NEWSWIRE) — Major Precious Metals Corp. (“Major Precious Metals” or the “Company”) (CSE:SIZE […]
Second Phase of Beyond Tobacco™ Market Research Underway with NV’s Largest Consumer Product Testing Firm
Following the first retail market testing phase for Beyond Tobacco™ in spring 2020 in which anecdotal user responses were collected […]
Altimmune and the University of Alabama at Birmingham (UAB) Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID™
GAITHERSBURG, Md., July 13, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced positive results […]
Axsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-05 for the Treatment of Major Depressive Disorder
NDA submission on track for 4Q 2020NEW YORK, July 13, 2020 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a […]
Summit Announces Publication of Phase 2 Clinical Analyses of Gut Microbiome Health
Summit Therapeutics plc (‘Summit’ or the ‘Company’)Summit Announces Publication of Phase 2 Clinical Analyses of Gut Microbiome HealthOxford, UK, and Cambridge, […]
Calithera Biosciences Initiates Phase 1b Trial of Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis
SOUTH SAN FRANCISCO, July 13, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused […]
EyePoint Pharmaceuticals Expands Executive Leadership Team with the Appointment of Jay S. Duker, M.D., as Chief Strategic Scientific Officer
– World-renowned retina specialist to lead EYP-1901 development efforts and support expansion of EyePoint’s ocular disease pipeline –WATERTOWN, Mass., July […]
